Genomic Valley Biotech Limited

Equities

GVBL6

INE574D01010

Market Closed - Bombay S.E. Other stock markets 06:00:57 2024-06-28 am EDT			5-day change	1st Jan Change
61.18 ^INR	+1.32%		+15.89%	+63.41%

May. 09	Genomic Valley Biotech Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI
Feb. 14	Genomic Valley Biotech Limited Announces Appointment of Mrs. Parul Agrawal as an Additional Non-Executive (Non-Independent) Director on the Board with Effect from February 14, 2024	CI

Deepti Aggarwal and Amar Aggarwal acquired 16.39% stake in Genomic Valley Biotech Ltd.

January 12, 2018

Deepti Aggarwal and Amar Aggarwal acquired 16.39% stake in Genomic Valley Biotech Ltd on December 29, 2017. Under the terms of the transaction, Deepti Aggarwal and Amar Aggarwal acquired 0.28 million and 0.22 million shares of Genomic Valley Biotech Ltd respectively. The stake holding of Deepti Aggarwal increased from 1.83% to 11% and stake holding of Amar Aggarwal increased from 1.83% to 9.05% in Genomic Valley Biotech Ltd. Deepti Aggarwal and Amar Aggarwal completed the acquisition of 16.39% stake in Genomic Valley Biotech Ltd on December 29, 2017.

Latest news about Genomic Valley Biotech Limited

Genomic Valley Biotech Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	May. 09	CI
Genomic Valley Biotech Limited Announces Appointment of Mrs. Parul Agrawal as an Additional Non-Executive (Non-Independent) Director on the Board with Effect from February 14, 2024	Feb. 14	CI
Genomic Valley Biotech Limited Announces Change in Corporate Office Address	Feb. 14	CI
Genomic Valley Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 14	CI
Genomic Valley Biotech Limited Announces Resignation of Mrs. Jyoti Bansal as Non-Executive (Independent) Director of the Company Effective December 14, 2023	Dec. 14	CI
Genomic Valley Biotech Limited Announces Resignation of Parul Agrawal as Non-Executive (Non-Independent) Director and Reconstitution of Committees	Nov. 14	CI
Genomic Valley Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 14	CI
Genomic Valley Biotech Limited Announces Executive Changes	23-09-30	CI
Genomic Valley Biotech Limited Approves Shifting of Registered Office	23-09-30	CI
Genomic Valley Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-14	CI
Genomic Valley Biotech Limited Appoints Yogesh Agrawal as Chief Financial Officer	23-06-30	CI
Genomic Valley Biotech Limited Announces Executive Changes	23-06-30	CI
Genomic Valley Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-29	CI
Genomic Valley Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	23-05-29	CI
Genomic Valley Biotech CFO Steps Down	23-04-02	MT
Genomic Valley Biotech Limited Announces CFO Changes	23-03-31	CI
Genomic Valley Biotech Limited Announces Change in Directorate	23-03-31	CI
Genomic Valley Biotech Limited Announces Resignation of Mr. Pritam as Company Secretary / Compliance Officer	23-03-02	CI
Genomic Valley Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-10	CI
Genomic Valley Biotech Limited Announces Appointment of Mr. Pritam as Company Secretary and Compliance Officer	22-12-21	CI
Genomic Valley Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-12	CI
Genomic Valley Biotech Turns to Net Profit in Fiscal Q1	22-07-20	MT
Genomic Valley Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-07-20	CI
Genomic Valley Biotech Limited Announces Resignation of Hanurnan Prasad as Company Secretary and Compliance Officer	22-06-23	CI
Genomic Valley Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	22-05-29	CI